Europe Pembrolizumab Market Report 2016

December 2016 | 105 pages | ID: E7C3EA09DCCEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pembrolizumab

Revenue, means the sales value of Pembrolizumab

This report studies sales (consumption) of Pembrolizumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Merck & Co., Inc.
• Novartis AG
• Onxeo SA
• Sumitomo Dainippon Pharma Co., Ltd.
• Taiwan Liposome Company, Ltd.
• Tiziana Life Sciences Plc

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Pembrolizumab in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Pembrolizumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Pembrolizumab Market Report 2016

1 PEMBROLIZUMAB OVERVIEW

1.1 Product Overview and Scope of Pembrolizumab
1.2 Classification of Pembrolizumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pembrolizumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Pembrolizumab Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Pembrolizumab (2011-2021)
  1.5.1 Europe Pembrolizumab Sales and Growth Rate (2011-2021)
  1.5.2 Europe Pembrolizumab Revenue and Growth Rate (2011-2021)

2 EUROPE PEMBROLIZUMAB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Pembrolizumab Market Competition by Manufacturers
  2.1.1 Europe Pembrolizumab Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Pembrolizumab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Pembrolizumab (Volume and Value) by Type
  2.2.1 Europe Pembrolizumab Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Pembrolizumab Revenue and Market Share by Type (2011-2016)
2.3 Europe Pembrolizumab (Volume and Value) by Countries
  2.3.1 Europe Pembrolizumab Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Pembrolizumab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Pembrolizumab (Volume) by Application

3 GERMANY PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Pembrolizumab Sales and Value (2011-2016)
  3.1.1 Germany Pembrolizumab Sales and Growth Rate (2011-2016)
  3.1.2 Germany Pembrolizumab Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Pembrolizumab Sales Price Trend (2011-2016)
3.2 Germany Pembrolizumab Sales and Market Share by Manufacturers
3.3 Germany Pembrolizumab Sales and Market Share by Type
3.4 Germany Pembrolizumab Sales and Market Share by Application

4 FRANCE PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 France Pembrolizumab Sales and Value (2011-2016)
  4.1.1 France Pembrolizumab Sales and Growth Rate (2011-2016)
  4.1.2 France Pembrolizumab Revenue and Growth Rate (2011-2016)
  4.1.4 France Pembrolizumab Sales Price Trend (2011-2016)
4.2 France Pembrolizumab Sales and Market Share by Manufacturers
4.3 France Pembrolizumab Sales and Market Share by Type
4.4 France Pembrolizumab Sales and Market Share by Application

5 UK PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Pembrolizumab Sales and Value (2011-2016)
  5.1.1 UK Pembrolizumab Sales and Growth Rate (2011-2016)
  5.1.2 UK Pembrolizumab Revenue and Growth Rate (2011-2016)
  5.1.5 UK Pembrolizumab Sales Price Trend (2011-2016)
5.2 UK Pembrolizumab Sales and Market Share by Manufacturers
5.3 UK Pembrolizumab Sales and Market Share by Type
5.4 UK Pembrolizumab Sales and Market Share by Application

6 RUSSIA PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Pembrolizumab Sales and Value (2011-2016)
  6.1.1 Russia Pembrolizumab Sales and Growth Rate (2011-2016)
  6.1.2 Russia Pembrolizumab Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Pembrolizumab Sales Price Trend (2011-2016)
6.2 Russia Pembrolizumab Sales and Market Share by Manufacturers
6.3 Russia Pembrolizumab Sales and Market Share by Type
6.4 Russia Pembrolizumab Sales and Market Share by Application

7 ITALY PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Pembrolizumab Sales and Value (2011-2016)
  7.1.1 Italy Pembrolizumab Sales and Growth Rate (2011-2016)
  7.1.2 Italy Pembrolizumab Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Pembrolizumab Sales Price Trend (2011-2016)
7.2 Italy Pembrolizumab Sales and Market Share by Manufacturers
7.3 Italy Pembrolizumab Sales and Market Share by Type
7.4 Italy Pembrolizumab Sales and Market Share by Application

8 SPAIN PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Pembrolizumab Sales and Value (2011-2016)
  8.1.1 Spain Pembrolizumab Sales and Growth Rate (2011-2016)
  8.1.2 Spain Pembrolizumab Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Pembrolizumab Sales Price Trend (2011-2016)
8.2 Spain Pembrolizumab Sales and Market Share by Manufacturers
8.3 Spain Pembrolizumab Sales and Market Share by Type
8.4 Spain Pembrolizumab Sales and Market Share by Application

9 BENELUX PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Pembrolizumab Sales and Value (2011-2016)
  9.1.1 Benelux Pembrolizumab Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Pembrolizumab Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Pembrolizumab Sales Price Trend (2011-2016)
9.2 Benelux Pembrolizumab Sales and Market Share by Manufacturers
9.3 Benelux Pembrolizumab Sales and Market Share by Type
9.4 Benelux Pembrolizumab Sales and Market Share by Application

10 EUROPE PEMBROLIZUMAB MANUFACTURERS ANALYSIS

10.1 Merck & Co., Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Pembrolizumab Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Merck & Co., Inc. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Novartis AG
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Pembrolizumab Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Novartis AG Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Onxeo SA
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Pembrolizumab Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Onxeo SA Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Sumitomo Dainippon Pharma Co., Ltd.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Pembrolizumab Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Taiwan Liposome Company, Ltd.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Pembrolizumab Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Taiwan Liposome Company, Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Tiziana Life Sciences Plc
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Pembrolizumab Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Tiziana Life Sciences Plc Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview

11 PEMBROLIZUMAB MANUFACTURING COST ANALYSIS

11.1 Pembrolizumab Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Pembrolizumab

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Pembrolizumab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE PEMBROLIZUMAB MARKET FORECAST (2016-2021)

14.1 Germany Pembrolizumab Sales Forecast (2016-2021)
14.2 France Pembrolizumab Sales Forecast (2016-2021)
14.3 UK Pembrolizumab Sales Forecast (2016-2021)
14.4 Russia Pembrolizumab Sales Forecast (2016-2021)
14.5 Italy Pembrolizumab Sales Forecast (2016-2021)
14.6 Spain Pembrolizumab Sales Forecast (2016-2021)
14.7 Benelux Pembrolizumab Sales Forecast (2016-2021)
14.8 Europe Pembrolizumab Sales Forecast by Type (2016-2021)
14.9 Europe Pembrolizumab Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pembrolizumab
Table Classification of Pembrolizumab
Figure Europe Sales Market Share of Pembrolizumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Pembrolizumab
Figure Europe Sales Market Share of Pembrolizumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure France Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure UK Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Russia Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Italy Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Spain Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Benelux Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Europe Pembrolizumab Sales and Growth Rate (2011-2021)
Figure Europe Pembrolizumab Revenue and Growth Rate (2011-2021)
Table Europe Pembrolizumab Sales of Key Manufacturers (2015 and 2016)
Table Europe Pembrolizumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pembrolizumab Sales Share by Manufacturers
Figure 2016 Pembrolizumab Sales Share by Manufacturers
Table Europe Pembrolizumab Revenue by Manufacturers (2015 and 2016)
Table Europe Pembrolizumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Pembrolizumab Revenue Share by Manufacturers
Table 2016 Europe Pembrolizumab Revenue Share by Manufacturers
Table Europe Pembrolizumab Sales and Market Share by Type (2011-2016)
Table Europe Pembrolizumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Pembrolizumab by Type (2011-2016)
Figure Europe Pembrolizumab Sales Growth Rate by Type (2011-2016)
Table Europe Pembrolizumab Revenue and Market Share by Type (2011-2016)
Table Europe Pembrolizumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pembrolizumab by Type (2011-2016)
Figure Europe Pembrolizumab Revenue Growth Rate by Type (2011-2016)
Table Europe Pembrolizumab Sales and Market Share by Countries (2011-2016)
Table Europe Pembrolizumab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Pembrolizumab by Countries (2011-2016)
Table Europe Pembrolizumab Revenue and Market Share by Countries (2011-2016)
Table Europe Pembrolizumab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Pembrolizumab by Countries (2011-2016)
Table Europe Pembrolizumab Sales and Market Share by Application (2011-2016)
Table Europe Pembrolizumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Pembrolizumab by Application (2011-2016)
Figure Germany Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Germany Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Germany Pembrolizumab Sales Price Trend (2011-2016)
Table Germany Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table Germany Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table Germany Pembrolizumab Sales by Type (2015 and 2016)
Table Germany Pembrolizumab Market Share by Type (2015 and 2016)
Table Germany Pembrolizumab Sales by Application (2015 and 2016)
Table Germany Pembrolizumab Market Share by Application (2015 and 2016)
Figure France Pembrolizumab Sales and Growth Rate (2011-2016)
Figure France Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure France Pembrolizumab Sales Price Trend (2011-2016)
Table France Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table France Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table France Pembrolizumab Sales by Type (2015 and 2016)
Table France Pembrolizumab Market Share by Type (2015 and 2016)
Table France Pembrolizumab Sales by Application (2015 and 2016)
Table France Pembrolizumab Market Share by Application (2015 and 2016)
Figure UK Pembrolizumab Sales and Growth Rate (2011-2016)
Figure UK Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure UK Pembrolizumab Sales Price Trend (2011-2016)
Table UK Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table UK Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table UK Pembrolizumab Sales by Type (2015 and 2016)
Table UK Pembrolizumab Market Share by Type (2015 and 2016)
Table UK Pembrolizumab Sales by Application (2015 and 2016)
Table UK Pembrolizumab Market Share by Application (2015 and 2016)
Figure Russia Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Russia Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Russia Pembrolizumab Sales Price Trend (2011-2016)
Table Russia Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table Russia Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table Russia Pembrolizumab Sales by Type (2015 and 2016)
Table Russia Pembrolizumab Market Share by Type (2015 and 2016)
Table Russia Pembrolizumab Sales by Application (2015 and 2016)
Table Russia Pembrolizumab Market Share by Application (2015 and 2016)
Figure Italy Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Italy Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Italy Pembrolizumab Sales Price Trend (2011-2016)
Table Italy Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table Italy Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table Italy Pembrolizumab Sales by Type (2015 and 2016)
Table Italy Pembrolizumab Market Share by Type (2015 and 2016)
Table Italy Pembrolizumab Sales by Application (2015 and 2016)
Table Italy Pembrolizumab Market Share by Application (2015 and 2016)
Figure Spain Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Spain Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Spain Pembrolizumab Sales Price Trend (2011-2016)
Table Spain Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table Spain Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table Spain Pembrolizumab Sales by Type (2015 and 2016)
Table Spain Pembrolizumab Market Share by Type (2015 and 2016)
Table Spain Pembrolizumab Sales by Application (2015 and 2016)
Table Spain Pembrolizumab Market Share by Application (2015 and 2016)
Figure Benelux Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Benelux Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Benelux Pembrolizumab Sales Price Trend (2011-2016)
Table Benelux Pembrolizumab Sales by Manufacturers (2015 and 2016)
Table Benelux Pembrolizumab Market Share by Manufacturers (2015 and 2016)
Table Benelux Pembrolizumab Sales by Type (2015 and 2016)
Table Benelux Pembrolizumab Market Share by Type (2015 and 2016)
Table Benelux Pembrolizumab Sales by Application (2015 and 2016)
Table Benelux Pembrolizumab Market Share by Application (2015 and 2016)
Table Pembrolizumab Basic Information List
Table Merck & Co., Inc. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. Pembrolizumab Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Pembrolizumab Sales Market Share (2011-2016)
Table Onxeo SA Basic Information List
Table Onxeo SA Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onxeo SA Pembrolizumab Sales Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Co., Ltd. Basic Information List
Table Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales Market Share (2011-2016)
Table Taiwan Liposome Company, Ltd. Basic Information List
Table Taiwan Liposome Company, Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiwan Liposome Company, Ltd. Pembrolizumab Sales Market Share (2011-2016)
Table Tiziana Life Sciences Plc Basic Information List
Table Tiziana Life Sciences Plc Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tiziana Life Sciences Plc Pembrolizumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pembrolizumab
Figure Manufacturing Process Analysis of Pembrolizumab
Figure Pembrolizumab Industrial Chain Analysis
Table Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015
Table Major Buyers of Pembrolizumab
Table Distributors/Traders List
Figure Germany Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Figure France Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure France Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure UK Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Pembrolizumab Sales Forecast by Type (2016-2021)
Table Europe Pembrolizumab Sales Forecast by Application (2016-2021)